Latest Financials News

Peninsula Energy outlines a revised production roadmap for its Lance uranium project in Wyoming, addressing commissioning delays and legacy contract burdens while securing fresh capital to fuel growth amid strong US nuclear energy momentum.

Peninsula Energy Limited launches a fully underwritten A$69.9 million equity raising to support the ramp-up of its Lance uranium project in Wyoming, alongside a strategic operational reset and leadership overhaul.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

RLF AgTech has successfully raised $4.5 million through a heavily oversubscribed placement, aiming to accelerate its Australian expansion and reduce leverage by cancelling convertible notes.

RLF AgTech has secured a national supply agreement with Nutrien Ag Solutions, granting access to over 700 rural retail outlets across Australia. This partnership aims to boost RLF’s domestic presence and support sustainable farming practices.

GDI has exchanged contracts to sell six assets from its Autoleague Portfolio for $74 million, marking a significant gain over original costs and setting the stage for substantial unitholder distributions.

Carbonxt Group Limited has launched a fully underwritten $0.7 million Loyalty Options entitlement offer to existing shareholders, aiming to support working capital and operational growth following its new Kentucky facility commissioning.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

Cue Energy Resources reported a 10% revenue increase to $54.8 million in FY2025, declaring a final dividend and advancing key development projects that underpin future growth.

Nyrada Inc. reported a sharp 25% decline in revenues alongside a 248% surge in net losses for the fiscal year ending June 2025, signaling mounting financial pressures for the pharmaceutical developer.

Monash IVF Group reported a 5.6% rise in underlying EBITDA for FY25, navigating a declining Australian IVF market and operational challenges. The company sets a cautious FY26 NPAT guidance of $20-23 million while focusing on regaining market leadership and implementing safety reforms.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.